Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 76 AL 90

Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease

Gueorguieva I, Willis BA, Chua L, Chow K, Ernest CS, Shcherbinin S, Ardayfio P, Mullins GR, Sims JR.

Clin Pharmacol Ther. 2023 Jun;113(6):1258-1267. doi: 10.1002/cpt.2875. Epub 2023 Mar 9.

Aberrant protein S-nitrosylation contributes to hyperexcitability-induced synaptic damage in Alzheimer's disease: Mechanistic insights and potential therapies

Ghatak S, Nakamura T, Lipton SA.

Front Neural Circuits. 2023 Feb 2;17:1099467. doi: 10.3389/fncir.2023.1099467. eCollection 2023.

The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET

Mohammadi Z, Alizadeh H, Marton J, Cumming P.

Biomolecules. 2023 Feb 3;13(2):290. doi: 10.3390/biom13020290.

Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders

Nirogi R, Jayarajan P, Shinde A, Mohammed AR, Grandhi VR, Benade V, Goyal VK, Abraham R, Jasti V, Cummings J.

Biomolecules. 2023 Feb 7;13(2):309. doi: 10.3390/biom13020309.

The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells

Cai W, Wu T, Chen N.

Biomolecules. 2023 Feb 7;13(2):313. doi: 10.3390/biom13020313.

How Can Insulin Resistance Cause Alzheimer's Disease?

Yoon JH, Hwang J, Son SU, Choi J, You SW, Park H, Cha SY, Maeng S.

Int J Mol Sci. 2023 Feb 9;24(4):3506. doi: 10.3390/ijms24043506.

Gut Microbiota and Alzheimer's Disease: How to Study and Apply Their Relationship

Nguyen NM, Cho J, Lee C.

Int J Mol Sci. 2023 Feb 17;24(4):4047. doi: 10.3390/ijms24044047.

Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study

Ding P, Gorenflo MP, Zhu X, Xu R.

J Alzheimers Dis. 2023;92(3):989-1000. doi: 10.3233/JAD-220787.

Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects

Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE.

Inflammopharmacology. 2023 Jun;31(3):1107-1115. doi: 10.1007/s10787-023-01163-7. Epub 2023 Feb 28.

Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Dubois B, López-Arrieta J, Lipschitz S, Doskas T, Spiru L, Moroz S, Venger O, Vermersch P, Moussy A, Mansfield CD, Hermine O, Tsolaki M; AB09004 Study Group Investigators.

Alzheimers Res Ther. 2023 Feb 28;15(1):39. doi: 10.1186/s13195-023-01169-x.

Lecanemab: First Approval

Hoy SM.

Drugs. 2023 Mar;83(4):359-365. doi: 10.1007/s40265-023-01851-2.

Insights on benzodiazepines' potential in Alzheimer's disease

Al-Kuraishy HM, Al-Gareeb AI, Alsayegh AA, Abusudah WF, Almohmadi NH, Eldahshan OA, Ahmed EA, Batiha GE.

Life Sci. 2023 May 1;320:121532. doi: 10.1016/j.lfs.2023.121532. Epub 2023 Feb 28.

The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double-blind, controlled trial

Tamtaji OR, Heidari-Soureshjani R, Asemi Z, Kouchaki E.

Phytother Res. 2023 Jul;37(7):2957-2964. doi: 10.1002/ptr.7791. Epub 2023 Mar 2.

Neuroinflammation in Alzheimer's disease: potential beneficial effects of vitamin D

Kouba BR, Camargo A, Rodrigues ALS.

Metab Brain Dis. 2023 Mar;38(3):819-829. doi: 10.1007/s11011-023-01188-5. Epub 2023 Mar 2.

Traditional Chinese Patent Medicine in the Treatment of Alzheimer's Disease: A Systematic Review and Network Meta-Analysis

Liu C, Zhang L, Li Y, Li M, Han H, Wang K.

Am J Chin Med. 2023;51(3):517-546. doi: 10.1142/S0192415X2350026X. Epub 2023 Feb 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias